Literature DB >> 14630240

Synthesis and hypolipidemic activity of N-substituted phthalimides. Part V.

Vera L M Sena1, Rajendra M Srivastava, Ricardo O Silva, Vera L M Lima.   

Abstract

A series of N-aryl- or N-(1,2,4-triazol-yl)-phthalimides (4a-4i) have been synthesized starting from phthalic anhydride (1) and an appropriate amine (2a-2i). All compounds presented hypolipidemic activity, but compound 4d proved to be the most active and reduced plasma cholesterol and triglyceride levels in Swiss white mice significantly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630240     DOI: 10.1016/S0014-827X(03)00185-X

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  4 in total

1.  Synthesis, structural and antioxidant studies of some novel N-ethyl phthalimide esters.

Authors:  C S Chidan Kumar; Wan-Sin Loh; Siddegowda Chandraju; Yip-Foo Win; Weng Kang Tan; Ching Kheng Quah; Hoong-Kun Fun
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

2.  Synthesis and anti-inflammatory activity of new alkyl-substituted phthalimide 1H-1,2,3-triazole derivatives.

Authors:  Shalom Pôrto de Oliveira Assis; Moara Targino da Silva; Ronaldo Nascimento de Oliveira; Vera Lúcia de Menezes Lima
Journal:  ScientificWorldJournal       Date:  2012-12-05

3.  A novel and highly regioselective synthesis of new carbamoylcarboxylic acids from dianhydrides.

Authors:  Adrián Ochoa-Terán; Jesús Estrada-Manjarrez; Marisela Martínez-Quiroz; Marco A Landey-Álvarez; Eleazar Alcántar Zavala; Georgina Pina-Luis; Hisila Santacruz Ortega; Luis Enrique Gómez-Pineda; José-Zeferino Ramírez; Daniel Chávez; Julio Montes Ávila; Victoria Labastida-Galván; Mario Ordoñez
Journal:  ScientificWorldJournal       Date:  2014-01-06

4.  Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos.

Authors:  Annalisa Mercurio; Lucy Sharples; Filomena Corbo; Carlo Franchini; Angelo Vacca; Alessia Catalano; Alessia Carocci; Roger D Kamm; Andrea Pavesi; Giulia Adriani
Journal:  Front Pharmacol       Date:  2019-04-17       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.